DID YOU KNOW? Over 130,000 Australians have Type 1 diabetes.
Type 1 diabetes is the most common chronic disease in children, and is more common than cancer and cystic fibrosis.
DID YOU KNOW? People with Type 1 diabetes face many serious long term health complications.
Type 1 diabetes is a lifelong incurable disease, and without daily insulin injections people with Type 1 diabetes would die.
DID YOU KNOW? The cost to Australia of Type 1 diabetes is estimated to be $600m per annum.
DID YOU KNOW? Over 275 people a day are newly diagnosed with Type 2 diabetes.
DID YOU KNOW? Nearly 1 million Australians have Type 2 diabetes.
DID YOU KNOW? The cost to Australia of diabetes is nearly $7billion per annum.
DID YOU KNOW? Over 60% of people with Type 2 diabetes can overcome it with fitness and healthy lifestyle.
Shopping cart is empty.
  1. Encourage, inspire and motivate people of all ages and backgrounds to improve their mental and physical health through running and exercise.
  2. Improve the public awareness of diabetes and depression, with particular emphasis on exercise and fitness as a component of managing these diseases.
  3. Development a range of tools and support services which will help Type 1 and Type 2 diabetics, and people with depression and other mood disorders to incorporate exercise into their lives to improve their physical fitness and mental health, which will in turn reduce the side effects and complications of their disease.
  4. Assist in funding the clinical trials of exT1D to enable it to assist people affected by Type 1 diabetes to participate in physical activity, sport and exercise with greater confidence and safety, and also enabling exT1D to be released in Australia and ultimately a global basis.
  5. Fund medical research, with an emphasis on finding a cure for Type 1 diabetes. Work with the Juvenile Diabetes Research Foundation (JDRF) to identify suitable and promising research projects that have the potential to progress towards a cure for Type 1 diabetes.

The Born to Run Foundation has set an goal of developing a business model to enable it to make a $5million funding commitment towards Type 1 diabetes research, as well as providing funds to assist in the clinical trials and development of exT1D.